Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Wani, Irshad
- Role of Trimetazidine in Preventing Myocardial Injury in Patients Undergoing Off Pump CABG
Abstract Views :51 |
PDF Views:0
Authors
Affiliations
1 Mch CTVS, Assistant Professor, Era Medical College, IN
2 KGMU Cardiology, Lucknow, IN
3 Batra Hospital & Medical Research Center, New Delhi, IN
1 Mch CTVS, Assistant Professor, Era Medical College, IN
2 KGMU Cardiology, Lucknow, IN
3 Batra Hospital & Medical Research Center, New Delhi, IN
Source
The Indian Practitioner, Vol 76, No 2 (2023), Pagination: 26-27Abstract
No Abstract.Keywords
No Keywords.References
- Saha KK.Off-pump coronary bypass grafting: the new gold standard. Indian J Thoracic Cardiovasc Surg.2018;34:3–5.
- Hoffman JW Jr, et al. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J Extra Corpor Technol. 2004;36:391-411.
- Zhang N, Lei J, Liu Q, Huang W, Xiao H, Lei H. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis. Cardiology. 2015;131:86-96.
- Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme - A thiolase. Circ Res. 2000;86(5):580-88.
- Turk T, Ata Y, Ufuk A, Hasan A, Kagan A, Senol Y. Efficacy of preoperative trimetazidine for preventing myocardial injury in patients undergoing off-pump coronary artery bypass grafting. Eur Res J. 2016;2:107-111.22222